Literature DB >> 6336714

Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.

K M de Bruijn, L M Blendis, D H Zilm, P L Carlen, G H Anderson.   

Abstract

Eight stable cirrhotic patients with mild or subclinical portal-systemic encephalopathy (PSE) were studied after shunt surgery when they were off all antiencephalopathic therapy. Equal amounts of mixed proteins were alternated with animal or vegetable protein in a crossover protocol under metabolic conditions for five consecutive, one week periods. The different dietary periods were not associated with either a change in the neurological impairment score or the Trailmaking Tests, which showed a learning effect. The peak frequencies of the computer analysed EEG (CAEEG) were lower during the animal (6.58 +/- 0.42 Hz) than the vegetable (7.10 +/- 0.44 Hz) diet (p 0.01). Neither arterial ammonia levels nor plasma amino acid ratios changed with the diets, whereas urinary 3-methyl-histidine excretion increased during the animal diet. During the vegetable diet the apparent nitrogen balance tended to be more positive than during either the mixed or animal diets associated with decrease in the urinary nitrogen excretion. The peak frequency of the CAEEG is the most sensitive test to monitor methods of treatment in portal-systemic encephalopathy. A vegetable protein diet, rather than overall protein restriction, should be considered in the management of this disorder, particularly when the nutritional state is poor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336714      PMCID: PMC1419916          DOI: 10.1136/gut.24.1.53

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  The application in general medical conditions of a visual method of assessing and representing generalized electroencephalographic abnormalities.

Authors:  J LAIDLAW
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-02       Impact factor: 10.154

2.  Methionine toxicity in liver disease and its prevention by chlortetracycline.

Authors:  E A PHEAR; B RUEBNER; S SHERLOCK; W H SUMMERSKILL
Journal:  Clin Sci       Date:  1956-02       Impact factor: 6.124

3.  A controlled study of the effects of L-arginine on hepatic encephalopathy.

Authors:  T B REYNOLDS; A G REDEKER; P DAVIS
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

4.  Encephalopathy after portacaval anastomosis.

Authors:  A E Read; C F McCarthy; A B Ajdukiewicz; G J Brown
Journal:  Lancet       Date:  1968-11-09       Impact factor: 79.321

5.  [The determination of urea in plasma and serum by a urease/Berthelot method, adapted to the Greiner Electronic Selective Analyzer GSA II (author's transl)].

Authors:  R Richterich; H Küffer
Journal:  Z Klin Chem Klin Biochem       Date:  1973-12

6.  Alcohol, protein metabolism, and liver injury.

Authors:  C S Lieber
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

7.  Reliability of assessment of alcohol intake based on personal interviews in a liver clinic.

Authors:  H Orrego; J E Blake; L M Blendis; B M Kapur; Y Israel
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

Review 8.  Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.

Authors:  V R Young; H N Munro
Journal:  Fed Proc       Date:  1978-07

9.  Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy.

Authors:  C J McClain; L Zieve; W M Doizaki; S Gilberstadt; G R Onstad
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

10.  The short-term effects of protein intake on 3-methylhistidine excretion.

Authors:  E B Marliss; C N Wei; L L Dietrich
Journal:  Am J Clin Nutr       Date:  1979-08       Impact factor: 7.045

View more
  11 in total

1.  Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.

Authors:  R K Dhiman; M S Sawhney; Y K Chawla; G Das; S Ram; J B Dilawari
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

3.  Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Authors:  Douglas L Nguyen; Timothy Morgan
Journal:  Hepatol Int       Date:  2014-09-01       Impact factor: 6.047

Review 4.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 5.  Minimal hepatic encephalopathy.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb

Review 6.  Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

Authors:  Daniela Campion; Ilaria Giovo; Paola Ponzo; Giorgio M Saracco; Federico Balzola; Carlo Alessandria
Journal:  World J Hepatol       Date:  2019-06-27

Review 7.  A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy.

Authors:  Umair Iqbal; Ravirajsinh N Jadeja; Harshit S Khara; Sandeep Khurana
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

Review 8.  Malnutrition in liver cirrhosis:the influence of protein and sodium.

Authors:  Sareh Eghtesad; Hossein Poustchi; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2013-04

9.  Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.

Authors:  Kapil Sharma; Sanjay Pant; Sriprakash Misra; Manisha Dwivedi; Alok Misra; Sushil Narang; Reshu Tewari; Ajeet S Bhadoria
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

Review 10.  Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease.

Authors:  Annarein J C Kerbert; Rajiv Jalan
Journal:  F1000Res       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.